Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans R Mehvar, DR Brocks | 373 | 2001 |
Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery KM Wasan, DR Brocks, SD Lee, K Sachs-Barrable, SJ Thornton Nature reviews Drug discovery 7 (1), 84-99, 2008 | 336 | 2008 |
A systematic review of drug absorption following bariatric surgery and its theoretical implications R Padwal, D Brocks, AM Sharma Obesity reviews 11 (1), 41-50, 2010 | 321 | 2010 |
Clinical pharmacokinetics of ketoprofen and its enantiomers F Jamali, DR Brocks Clinical pharmacokinetics 19 (3), 197-217, 1990 | 287 | 1990 |
High‐performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin Z Ma, A Shayeganpour, DR Brocks, A Lavasanifar, J Samuel Biomedical Chromatography 21 (5), 546-552, 2007 | 244 | 2007 |
Anticholinergic drugs used in Parkinson's disease: An overlooked class of drugs from a pharmacokinetic perspective DR Brocks J Pharm Pharm Sci 2 (2), 39-46, 1999 | 230 | 1999 |
Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics DR Brocks Biopharmaceutics & drug disposition 27 (8), 387-406, 2006 | 172 | 2006 |
Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution HM Aliabadi, DR Brocks, A Lavasanifar Biomaterials 26 (35), 7251-7259, 2005 | 169 | 2005 |
Clinical pharmacokinetics of ketorolac tromethamine DR Brocks, F Jamali Clinical pharmacokinetics 23 (6), 415-427, 1992 | 163 | 1992 |
Multiple peaking phenomena in pharmacokinetic disposition NM Davies, JK Takemoto, DR Brocks, JA Yáñez Clinical pharmacokinetics 49, 351-377, 2010 | 161 | 2010 |
Suppression of drug-metabolizing enzymes and efflux transporters in the intestine of endotoxin-treated rats J Kalitsky-Szirtes, A Shayeganpour, DR Brocks, M Piquette-Miller Drug Metabolism and Disposition 32 (1), 20-27, 2004 | 154 | 2004 |
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma AM Molina, DR Feldman, MH Voss, MS Ginsberg, MS Baum, DR Brocks, ... Cancer 118 (7), 1868-1876, 2012 | 142 | 2012 |
Stereoselectivity in the pharmacodynamics and pharmacokinetics of the chiral antimalarial drugs DR Brocks, R Mehvar Clinical pharmacokinetics 42, 1359-1382, 2003 | 141 | 2003 |
Metformin and exercise in type 2 diabetes: examining treatment modality interactions NG Boulé, C Robert, GJ Bell, ST Johnson, RC Bell, RZ Lewanczuk, ... Diabetes care 34 (7), 1469-1474, 2011 | 133 | 2011 |
Effect of gastric bypass surgery on the absorption and bioavailability of metformin RS Padwal, RQ Gabr, AM Sharma, LA Langkaas, DW Birch, S Karmali, ... Diabetes care 34 (6), 1295-1300, 2011 | 121 | 2011 |
Variations in tissue selectivity amongst insulin secretagogues: a systematic review AS Abdelmoneim, SE Hasenbank, JM Seubert, DR Brocks, PE Light, ... Diabetes, obesity and metabolism 14 (2), 130-138, 2012 | 116 | 2012 |
Metabolic acidosis: separation methods and biological relevance of organic acids and lactic acid enantiomers JB Ewaschuk, GA Zello, JM Naylor, DR Brocks Journal of Chromatography B 781 (1-2), 39-56, 2002 | 102 | 2002 |
Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat‐meal rat models A Shayeganpour, AS Jun, DR Brocks Biopharmaceutics & drug disposition 26 (6), 249-257, 2005 | 100 | 2005 |
Etodolac clinical pharmacokinetics DR Brocks, F Jamali Clinical pharmacokinetics 26 (4), 259-274, 1994 | 96 | 1994 |
Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs R Mehvar, DR Brocks, M Vakily Clinical pharmacokinetics 41, 533-558, 2002 | 95 | 2002 |